Abbott Laboratories (ABT) Assets Average (2009 - 2026)

Abbott Laboratories has disclosed Assets Average across 18 years of filings, most recently posting $98.6 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $98.6 billion, up 21.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.6 billion (up 21.05% YoY), and the FY2025 annual result was $84.1 billion, up 8.73% from the prior year.
• Assets Average came in at $98.6 billion for Q1 2026 at Abbott Laboratories, up from $85.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $98.6 billion in Q1 2026 to a low of $37.8 billion in Q4 2022.
• The 5-year median for Assets Average is $73.6 billion (2023), against an average of $71.3 billion.
• Across the five-year window, Assets Average retreated 6.63% in 2022 and surged 91.99% in 2023, its largest moves.
• Abbott Laboratories' Assets Average stood at $37.8 billion in 2022, then surged by 91.99% to $72.7 billion in 2023, then advanced by 7.2% to $77.9 billion in 2024, then advanced by 9.71% to $85.4 billion in 2025, then increased by 15.36% to $98.6 billion in 2026.
• The last three Assets Average figures came in at $98.6 billion (Q1 2026), $85.4 billion (Q4 2025), and $84.1 billion (Q3 2025), per Business Quant data.